Profil
Frans C.
Strassen is currently a Director at HMGene, Inc. He was previously the President & Chief Executive Officer at ProScript, Inc.
Aktive Positionen von Frans C. Strassen
| Unternehmen | Position | Beginn |
|---|---|---|
HMGene, Inc.
 HMGene, Inc. Pharmaceuticals: OtherHealth Technology HMGene, Inc. provides medical services. The company was founded on April 7, 2006 and is headquartered in North Brunswick, NJ. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Frans C. Strassen
| Unternehmen | Position | Ende |
|---|---|---|
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
HMGene, Inc.
HMGene, Inc. Pharmaceuticals: OtherHealth Technology HMGene, Inc. provides medical services. The company was founded on April 7, 2006 and is headquartered in North Brunswick, NJ. | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
